Similar articles

• Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada.

  Risch HA, McLaughlin JR, Cole DE, Rosen B, Bradley L, Fan I, Tang J, Li S, Zhang S, Shaw PA, Narod SA. Risch HA, et al. J Natl Cancer Inst. 2006 Dec 6;98(23):1694-706. doi: 10.1093/jnci/djj465. J Natl Cancer Inst. 2006. PMID: 17148771
• Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.

  Casey MJ, Synder C, Bewtra C, Narod SA, Watson P, Lynch HT. Casey MJ, et al. Gynecol Oncol. 2005 May;97(2):457-67. doi: 10.1016/j.ygyno.2005.01.039. Gynecol Oncol. 2005. PMID: 15863145
• BRCA1 and BRCA2 mutations in women with familial or early-onset breast/ovarian cancer in the Czech Republic.

  Foretova L, Machackova E, Navratilova M, Pavlu H, Hruba M, Lukesova M, Valik D. Foretova L, et al. Hum Mutat. 2004 Apr;23(4):397-8. doi: 10.1002/humu.9226. Hum Mutat. 2004. PMID: 15024741
• High proportion of recurrent germline mutations in the BRCA1 gene in breast and ovarian cancer patients from the Prague area.

  Pohlreich P, Zikan M, Stribrna J, Kleibl Z, Janatova M, Kotlas J, Zidovska J, Novotny J, Petruzelka L, Szabo C, Matous B. Pohlreich P, et al. Breast Cancer Res. 2005;7(5):R728-36. doi: 10.1186/bcr1282. Epub 2005 Jul 19. Breast Cancer Res. 2005. PMID: 16168118 Free PMC article.
• A high occurrence of BRCA1 and BRCA2 mutations among Czech hereditary breast and breast-ovarian cancer families.

  Machácková E, Foretová L, Navrátilová M, Valík D, Claes K, Messiaen L. Machácková E, et al. Cas Lek Cesk. 2000 Oct 11;139(20):635-7. Cas Lek Cesk. 2000. PMID: 11192759